Discount agreement for Follitropin alfa biologics
Original notice title
Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2026-25 - Follitropin alfa
Opportunity Score
Why this score?
Opportunity
46 / 100
Complexity
58 / 100
Risk factors
The notice says offers/contracts cannot be submitted via the portal; they must be sent by email with qualified electron...
Participation is limited to pharmaceutical entrepreneurs for the relevant medicinal products and requires the stated au...
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Overview
Moderate opportunityKey Facts
- Supplies contract
- 3 lots
- Duration until Jul 2028
- Open House discount agreements for pharmaceutical products under § 130a(8) SGB V for the active substance Follitropin alfa.
- Three lots are formed for specific branded medicines: GONAL-f, Bemfola, and Ovaleap.
Show full summary
Open House procedure by Techniker Krankenkasse for supply-side pharmaceutical discount agreements under § 130a(8) SGB V for the active substance Follitropin alfa. Three lots are listed for specific branded medicines (GONAL-f, Bemfola, Ovaleap). The procedure is non-exclusive, with no individual negotiations, and contracts may be concluded with all eligible pharmaceutical companies that meet the stated self-declarations and sign the contract in text form/electronic form as required. Submission is not via the portal; contracts must be sent by email with qualified electronic signature or by post. Procurement documents are available on the portal, but only extracted XML notice text was provided here, not the full document set.
Risks
The notice says offers/contracts cannot be submitted via the portal; they must be sent by email with qualified electron...
Participation is limited to pharmaceutical entrepreneurs for the relevant medicinal products and requires the stated au...
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Technical
- Tenderer must be a pharmaceutical entrepreneur within the meaning of § 4(18) AMG for the offered medicinal product(s).
- Tenderer must have its registered seat in the AMG territory, another EU Member State, or another EEA state.
- Tenderer must hold a valid marketing authorisation for the relevant medicinal product(s) or otherwise be entitled to place them on the market in its own name.
Buyer
Location
Hamburg, DEU
Website
Identifier
992-80116-93
Activity
Health
Lots (3)
LOT-0001
Follitropin alfa (GONAL-f)
Supply lot for Follitropin alfa covering the branded medicinal product GONAL-f. The lot is part of an Open House discount agreement scheme; no exclusivity and no individual negotiations apply. Performance is nationwide in Germany.
Location
Duration
Category
Deadline
Award details
Die TK verfolgt das Ziel, mit allen geeigneten pharmazeutischen Unternehmern Rabattverträge nach § 130a Abs. 8 SGB V zu dem Wirkstoff Follitropin alfa zu schließen.
Value note
Show original TED data
Original lot title
Follitropin alfa (Fertigarzneimittel GONAL-f (R))
Original TED description
Die TK verfolgt das Ziel, mit allen geeigneten pharmazeutischen Unternehmern Rabattverträge nach § 130a Abs. 8 SGB V zu dem Wirkstoff Follitropin alfa zu schließen.
LOT-0002
Follitropin alfa (Bemfola)
Supply lot for Follitropin alfa covering the branded medicinal product Bemfola. The lot is part of an Open House discount agreement scheme; no exclusivity and no individual negotiations apply. Performance is nationwide in Germany.
Location
Duration
Category
Deadline
Award details
Die TK verfolgt das Ziel, mit allen geeigneten pharmazeutischen Unternehmern Rabattverträge nach § 130a Abs. 8 SGB V zu dem Wirkstoff Follitropin alfa zu schließen.
Value note
Show original TED data
Original lot title
Follitropin alfa (Fertigarzneimittel Bemfola (R))
Original TED description
Die TK verfolgt das Ziel, mit allen geeigneten pharmazeutischen Unternehmern Rabattverträge nach § 130a Abs. 8 SGB V zu dem Wirkstoff Follitropin alfa zu schließen.
LOT-0003
Follitropin alfa (Ovaleap)
Supply lot for Follitropin alfa covering the branded medicinal product Ovaleap. The lot is part of an Open House discount agreement scheme; no exclusivity and no individual negotiations apply. Performance is nationwide in Germany.
Location
Duration
Category
Deadline
Award details
Die TK verfolgt das Ziel, mit allen geeigneten pharmazeutischen Unternehmern Rabattverträge nach § 130a Abs. 8 SGB V zu dem Wirkstoff Follitropin alfa zu schließen.
Value note
Show original TED data
Original lot title
Follitropin alfa (Fertigarzneimittel Ovaleap(R))
Original TED description
Die TK verfolgt das Ziel, mit allen geeigneten pharmazeutischen Unternehmern Rabattverträge nach § 130a Abs. 8 SGB V zu dem Wirkstoff Follitropin alfa zu schließen.
Procurement Details
- Publication date
- 07 Jun 2026
- Languages
- German
Reference metadata
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 388432-2026
Documents (1)
Similar tenders
Germany – Site preparation work – VE111 Baustelleneinrichtung (119VM514 / Kronsh,SanDstBw,Ersatzneub. ZInstSanBw)
Poland – Advertising and marketing services – Zaplanowanie i realizacja kampanii Ministerstwa Finansów z zakresu działalności resortu finansów
France – Insurance services – Prestations de services d'assurance pour groupement le groupement hospitalier de territoire Yvelines Nord
Finland – Architectural, construction, engineering and inspection services – Tietomallikoordinaattori-, inventointimittaus- ja mallinnuspalvelujen puitejärjestely 2026-2028 (2028-2030)
Greece – Cultural event organisation services – ΛΕΙΤΟΥΡΓΙΑ ΤΟΥ ΘΕΑΤΡΟΥ ΟΛΥΜΠΙΑ ΜΑΡΙΑ ΚΑΛΛΑΣ ΜΕ ΕΞΕΙΔΙΚΕΥΜΕΝΟ ΠΡΟΣΩΠΙΚΟ
Spain – Architectural, construction, engineering and inspection services – Redacción del Proyecto Básico y de Ejecución, Redacción del Estudio de Seguridad y Salud y Dirección de Obra para la construcción del I.E.S. Nº 1 de 12+0 uds. (Fase 1) en la urbanización El Bosque de Pioz (Guadalajara).
Opportunity Score
Why this score?
Opportunity
46 / 100
Complexity
58 / 100
Risk factors
The notice says offers/contracts cannot be submitted via the portal; they must be sent by email with qualified electron...
Participation is limited to pharmaceutical entrepreneurs for the relevant medicinal products and requires the stated au...
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications